MARKERS OF EXTRACELLULAR MATRIX TURNOVER AND RISK OF DEATH IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: RESULTS FROM I-PRESERVE

被引：2
|
作者：
Chow, Sheryl L. [1 ]
Krum, Henry [1 ]
O'Barr, Stephen A. [1 ]
Zile, Michael [1 ]
Carson, Peter [1 ]
Komajda, Michel [1 ]
McMurray, John [1 ]
Anand, Inderjit [1 ]
机构：
[1] Western Univ Hlth Sci, Pomona, CA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(15)60969-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1216-192
引用
收藏
页码：A969 / A969
页数：1
相关论文
共 50 条
  • [11] HEART FAILURE WITH PRESERVED EJECTION FRACTION: MORTALITY RISK POST FIRST HOSPITALIZATION - DATA FROM I-PRESERVE
    Carson, Peter E.
    Zile, Michael
    McMurray, John
    McKelvie, Robert
    Komajda, Michel
    Hetzel, Scott
    DeMets, David
    Staiger, Christoph
    Ptaszynska, Agata
    Massie, Barry
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [12] BASELINE SYSTOLIC BLOOD PRESSURE AND OUTCOMES IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION - RESULTS FROM THE I-PRESERVE TRIAL
    Anand, Inderjit S.
    Hetzel, Scott J.
    Miller, Alan B.
    Carson, Peter E.
    Gaasch, William H.
    Haass, Markus
    Little, William C.
    Lopez-Sendon, Jose
    Massie, Barry M.
    McMurray, John J.
    Ptaszynska, Agata
    Teerlink, John R.
    White, Michel
    Zile, Michael R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [13] Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction The Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial
    Lam, Carolyn S. P.
    Carson, Peter E.
    Anand, Inder S.
    Rector, Thomas S.
    Kuskowski, Michael
    Komajda, Michel
    McKelvie, Robert S.
    McMurray, John J.
    Zile, Michael R.
    Massie, Barry M.
    Kitzman, Dalane W.
    CIRCULATION-HEART FAILURE, 2012, 5 (05) : 571 - 578
  • [14] Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial
    McMurray, John J. V.
    Carson, Peter E.
    Komajda, Michel
    McKelvie, Robert
    Zile, Michael R.
    Ptaszynska, Agata
    Staiger, Christoph
    Donovan, J. Mark
    Massie, Barry M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (02) : 149 - 156
  • [15] The Relation of Quality of Life Score to Outcome in Heart Failure With Preserved Ejection Fraction: Findings From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial (I-PRESERVE)
    Carson, Peter
    Komajda, Michel
    Zile, Michael
    Johnson, Ralph H.
    Hetzel, Scott
    Mckelvie, Robert
    McMurray, John
    Staiger, Christoph
    Ptaszynska, Agata
    Massie, Barry
    CIRCULATION, 2009, 120 (18) : S749 - S749
  • [16] Does angiotensin receptor blockade improve outcomes in patients with heart failure and preserved ejection fraction? Results of the I-PRESERVE study
    Henry Krum
    Current Heart Failure Reports, 2009, 6 (2) : 65 - 67
  • [17] Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction)
    Kristensen, Soren L.
    Mogensen, Ulrik M.
    Jhund, Pardeep S.
    Petrie, Mark C.
    Preiss, David
    Win, Sithu
    Kober, Lars
    McKelvie, Robert S.
    Zile, Michael R.
    Anand, Inder S.
    Komajda, Michel
    Gottdiener, John S.
    Carson, Peter E.
    McMurray, John J. V.
    CIRCULATION, 2017, 135 (08) : 724 - +
  • [18] Risk of Clinical Outcomes and Baseline Atrial Fibrillation: Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial
    Oluleye, Oludamilola
    Win, Sithu
    Rector, Thomas
    Komadja, Michel
    Zile, Michael
    Mckelvie, Robert
    McMurray, John
    Massie, Barry
    Carson, Peter
    Anand, Inderjit
    CIRCULATION, 2013, 128 (22)
  • [19] ARTERIAL STIFFNESS CORRELATES WITH EXTRACELLULAR MATRIX TURNOVER IN HEART FAILURE WITH PRESERVED EJECTION FRACTION PATIENTS
    Martinez-Marin, M.
    Perez-Calvo, J.
    Josa-Laorden, C.
    Lacambra-Blasco, I.
    Gimenez-Lopez, I.
    Rubio-Gracia, J.
    Garces-Horna, V.
    Sanchez-Marteles, M.
    Ruiz-Laiglesia, F.
    Samperiz-Legarre, P.
    Torres-Courchoud, I.
    Amores-Arriaga, B.
    Martinez-Marin, R.
    Sanz-Bescos, C.
    Roncales-Garcia Blanco, F.
    ATHEROSCLEROSIS, 2016, 252 : E163 - E163
  • [20] The Prognostic Value of Insulin-like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Ejection Fraction: Results From Irbesartan in Heart Failure and Preserved Ejection Fraction (I-PRESERVE) Trial
    Gandhi, Parul U.
    Chow, Sheryl L.
    Rector, Thomas S.
    Krum, Henry
    Gaggin, Hanna K.
    McMurray, John J.
    Zile, Michael
    Komajda, Michel
    McKelvie, Robert S.
    Carson, Peter E.
    Januzzi, James L.
    Anand, Inder S.
    CIRCULATION, 2015, 132
12345